Anticoagulant Reversal Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2026

Nov 2019| FMR550A| Fact Market Research

Report Highlights

Anticoagulant Reversal Drugs Market - Scope of the Study

The study on the anticoagulant reversal drugs market is an exclusive report published by Fact.MR, which provides information regarding the key growth influencers of the landscape. This study offers insights on the growth of the anticoagulant reversal drugs market, by analysing the historical data for the period of 2016 - 2019, and 2020 - 2026 as the forecast period. Estimation of the revenue of the anticoagulant reversal drugs market has been carried out in terms of value (US$ Mn). This exclusive report focuses on offering information on the key trends that are likely to influence the growth of the anticoagulant reversal drugs market, in addition to crucial microscopic and macroeconomic growth indicators. The incisive report offers the key dynamics, along with their influence on the value chain, which is projected to positively impact the future growth of the anticoagulant reversal drugs market.

The study also includes a detailed section dedicated to impeders that could challenge the growth of players in the anticoagulant reversal drugs market. The report unfolds profitable opportunities for market players, which can be leveraged to consolidate their position in the global market. With a view of aiding stakeholders in the anticoagulant reversal drugs market, the study includes a detailed section on the competition landscape of the anticoagulant reversal drugs market. The study provides a dashboard view of the report, with a detailed comparison of players operating in the anticoagulant reversal drugs market, based on total revenue, market presence, and key developments. In addition to this, key strategies and recent developments implemented by players in the anticoagulant reversal drugs market have also been included in this comprehensive study.

Besides magnifying focus on the crucial segments, this exclusive study also offers information on the anticoagulant reversal drugs market at a country level, to identify the underlying opportunities available for players in the anticoagulant reversal drugs market for the forecast period. Among all the estimated data, the report also includes Y-o-Y growth projections, which can help market players in comprehending the precise trajectory at which the anticoagulant reversal drugs market has been growing.

Key companies profiled in the anticoagulant reversal drugs market include Perosphere Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Portola Pharmaceuticals, Inc., CSL Limited, Octapharma AG, Amneal Pharmaceuticals Inc., Bausch Health Companies, Inc., Fresenius Kabi AG, and Pfizer, Inc.

Anticoagulant Reversal Drugs Market - Research Methodology

The anticoagulant reversal drugs market has been evaluated by taking a top-down and bottom-up approach. Demand, geographical presence, distribution strategies by manufacturers, and initiatives taken by governments and NGOs are various factors considered while estimating the revenue of the anticoagulant reversal drugs market, and thus, reaching global numbers. The study on the anticoagulant reversal drugs market is further validated through extensive primary research on the data extracted from exhaustive secondary research.

In order to conduct secondary research, annual company reports, company websites, data from the World Health Organization (WHO), SEC filings, press releases, investor presentations, and other similar resources were studied. Both, the top-down and bottom-up approaches were undertaken by analysts of the report to find accurate data regarding the growth of the anticoagulant reversal drugs market. To validate the information compiled through secondary research, interviews with key opinion leaders and subject matter experts were scheduled. The analysis aims at studying the business environment, unmet needs of consumers, key restraints, historical sales pattern, and investment landscape. In addition to this, authors of the report also had email and telephonic interactions with the senior management of leading and prominent companies to confirm the size, growth trends, and future outlook of the anticoagulant reversal drugs market.

  • Table 1 : Reimbursement Scenario for AndeXXa
  • Table 2 : Reimbursement Scenario for Praxbind
  • Table 3 : Reimbursement Scenario for Kcentra
  • Table 4 : Pipeline Analysis
  • Table 5 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 6 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 7 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Region, 2016–2026
  • Table 8 : North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
  • Table 9 : North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 10 : North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 11 : Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 12 : Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 13 : Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 14 : Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 15 : Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 16 : Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 17 : Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 18 : Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 19 : Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 20 : Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 21 : Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 22 : Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Figure 1 : Anticoagulant Reversal Drugs Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 2 : Global Anticoagulant Reversal Drugs Market Size (US$ Mn) and Forecast, 2018–2026
  • Figure 3 : Market Value Share, by Product (2018)
  • Figure 4 : Market Value Share, by Distribution Channel (2018)
  • Figure 5 : Market Value Share, by Region (2018)
  • Figure 6 : Regulatory Approval Process - U.S.
  • Figure 7 : Regulatory Approval Process - Europe
  • Figure 8 : Regulatory Approval Process - Japan
  • Figure 9 : Global Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 10 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Prothrombin Complex Concentrates (PCC) 2016–2026
  • Figure 11 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Vitamin K, 2016–2026
  • Figure 12 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Protamine, 2016–2026
  • Figure 13 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Tranexamic Acid, 2016–2026
  • Figure 14 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 15 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Idarucizumab, 2016–2026
  • Figure 16 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by AndeXXa, 2016–2026
  • Figure 17 : Global Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 18 : Global Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 19 : Global Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 20 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospital Pharmacies, 2016–2026
  • Figure 21 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Retail Pharmacies, 2016–2026
  • Figure 22 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 23 : Global Anticoagulant Reversal Drugs Market Value Share, by Region, 2017 and 2026
  • Figure 24 : Global Anticoagulant Reversal Drugs Market Attractiveness, by Region, 2018–2026
  • Figure 25 : North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 26 : North America Anticoagulant Reversal Drugs Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 27 : North America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 28 : North America Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 29 : North America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 30 : North America Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 31 : North America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 32 : Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 33 : Europe Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 34 : Europe Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 35 : Europe Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 36 : Europe Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 37 : Europe Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 38 : Europe Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 39 : Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 40 : Asia Pacific Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 41 : Asia Pacific Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 42 : Asia Pacific Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 43 : Asia Pacific Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 44 : Asia Pacific Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 45 : Asia Pacific Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 46 : Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 47 : Latin America Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 48 : Latin America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 49 : Latin America Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 50 : Latin America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 51 : Latin America Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 52 : Latin America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 53 : Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 54 : Middle East & Africa Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 55 : Middle East & Africa Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 56 : Middle East & Africa Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 57 : Middle East & Africa Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 58 : Middle East & Africa Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 59 : Middle East & Africa Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 60 : Global Anticoagulant Reversal Drugs Market Share Analysis, by Company (2018)
  • Figure 61 : Product Overview - Bausch Health Companies, Inc.
  • Figure 62 : Breakdown of Net Sales (%), by Region, 2017 - Bausch Health Companies, Inc.
  • Figure 63 : Revenue (US$ Mn), 2015–2017 - Bausch Health Companies, Inc.
  • Figure 64 : R&D Expenses (US$ Mn), 2015-2017 - Bausch Health Companies, Inc.
  • Figure 65 : Product Overview - Pfizer, Inc.
  • Figure 66 : Breakdown of Net Sales, by Region, 2017 - Pfizer, Inc.
  • Figure 67 : Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017 - Pfizer, Inc.
  • Figure 68 : R&D Intensity and Sales & Marketing Intensity - Company Level, 2016–2017 - Pfizer, Inc.
  • Figure 69 : Product Overview - Fresenius Kabi AG
  • Figure 70 : Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017 - Fresenius Kabi AG
  • Figure 71 : Breakdown of Net Sales, by Region, 2017 - Fresenius Kabi AG
  • Figure 72 : Breakdown of Net Sales, by Segment, 2017 - Fresenius Kabi AG
  • Figure 73 : Research & Development Cost, 2016 - 2017 (US$ Mn) - Fresenius Kabi AG
  • Figure 74 : Product Overview - Amneal Pharmaceuticals, Inc.
  • Figure 75 : Product Overview - Boehringer Ingelheim GmbH
  • Figure 76 : Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017 - Boehringer Ingelheim GmbH
  • Figure 77 : Breakdown of Net Sales, by Business and Business Segment Level, 2017 - Boehringer Ingelheim GmbH
  • Figure 78 : Breakdown of Net Sales, by Region (Company Level), 2017 - Boehringer Ingelheim GmbH
  • Figure 79 : R&D Expenditure (US$ Bn), 2013–2017 - Boehringer Ingelheim GmbH
  • Figure 80 : Product Overview: CSL Limited
  • Figure 81 : Total Revenue (US$ Mn) and Y-o-Y Growth, 2016–2018-CSL Limited
  • Figure 82 : R&D Investment, (US$ Mn) and Y-o-Y Growth, 2016–2018 - CSL Limited
  • Figure 83 : Sales Revenue (US$ Mn) and Y-o-Y Growth, 2016–2018 - CSL Limited
  • Figure 84 : Net Profit (US$ Mn), 2016–2018 - CSL Limited
  • Figure 85 : Product Overview - Octapharma AG
  • Figure 86 : Revenue (US$ Mn) and Y-o-Y Growth, 2015–2017 - Octapharma AG
  • Figure 87 : R&D and Selling and Marketing Expenses, (US$ Mn), 2016–2017 - Octapharma AG
  • Figure 88 : Year-end Employee Headcount and Y-o-Y Growth, 2015-2017 - Octapharma AG
  • Figure 89 : Gross profit (US$ Mn) and Y-o-Y Growth, 2016–2017 - Octapharma AG
  • Figure 90 : Product Overview - Portola Pharmaceuticals, Inc.
  • Figure 91 : R&D and Selling and Marketing Expenses, (US$ Mn), 2016–2017 - Portola Pharmaceuticals, Inc.
  • Figure 92 : Revenue (US$ Mn) and Y-o-Y Growth, 2015–2017 - Portola Pharmaceuticals, Inc.
  • Figure 93 : Product Overview - Perosphere Pharmaceuticals Inc.

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report